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Recentprogress intheﬁeld ofepigeneticshas provideda new
studyangleforourresearch eﬀortsonreproductivemedicine
and gynecologic malignancies. We have acquired valuable
insight into the regulatory mechanism and biological eﬀects
of DNA methylation and histone modiﬁcation, the two
major epigenetic pathways. The newly acquired knowledge
eﬀectively complements that gained from the genetic stand-
point and holds great potential for the prevention,diagnosis,
risk assessment, and treatment of these diseases. Speciﬁcally,
the DNA methylation and imprinting mechanisms are
implicated in fertilization, early embryonic development,
placental function, and pathogenesis of preeclampsia and
intrauterine growth retardation. Aberrant DNA methylation
and chromatin modiﬁcation lead to gene-speciﬁc silencing
of numerous tumor suppressor genes, DNA repair genes,
and steroid hormone receptors. This special issue presents
a collection of peer-reviewed papers focusing on these
areas. While the issue is not intended as an exhaustive
representation of all of the potential topics, they nevertheless
provide insightful and multifaceted information that we
consider a pleasure to share with the readers.
This special issue includes 9 articles: three of which are
related to the IGF-II imprinting in placenta and the eﬀects
of reproduction procedures on imprinting; two describe epi-
genetic mechanisms and genetic test for infertility; another
paper documents the eﬀects of in vitro maturation on
histone acetylation in oocytes and early cleavage embryos;
two address DNA methylation changes in cancers; one paper
discusses rational design of primer for methylation assays.
Intheﬁrst paperentitled“Eﬀects ofin vitro maturationon
histone acetylation in metaphase II oocytes and early cleavage
embryos,” Wang et al. document a reduced expression
of histone acetyltransferase GCN5 (GCN5) and histone
deacetylase 1 (HDAC1) in two-cell embryos but a normal
level of these enzymes after the two-cell stage. The results
indicate that in vitro maturation could aﬀect protein and
gene expression related to histone acetylation in oocytes and
early cleavage embryos. However, by function of selection,
parts of the changes could be recovered in late embryo
development.
In the second paper entitled “Imprinting and promoter
usage of insulin-like growth factor II in twin discordant pla-
centa,” Luo et al. analyze the imprinting and promoter usage
of IGF-II in placenta of normal twins and twins with weight
or phenotype discordance and conclude that promoter 3
speciﬁc LOI of the IGF-II gene may be closely related to
phenotype discordance, but not to weight discordance.
In the third paper entitled “Oxidative stress and DNA
methylation in prostate cancer,” Donkena et al. present a
comprehensive review on the eﬀects of oxidative stress on
DNA methylation and cancer progression, life style and diet
as factors involved in ontogenesis and epigenetic interference
for cancer prevention, and DNA methylation as a biomarker
for cancer detection. Updates on the application of DNMT
inhibitors to chemotherapy are also provided.
In the fourth paper entitled “Preimplantation genetic
screening: an eﬀective testing for infertile and repeated miscar-
riage patients?,” Wang et al. compare results from diﬀerent2 Obstetrics and Gynecology International
laboratoriesonpreimplantation screening ofaneuploidyand
assess the eﬃcacy, risks, and beneﬁts of the procedure. They
conclude that the use of preimplantation genetic screening
should be reconsidered.
In the ﬁfth paper entitled “Study on the imprinting status
of insulin-like growth factor II (IGF-II) gene in villus during
6–10 gestational weeks,” Chen et al. compared the rate of loss
of GF-II imprinting in the placental villous tissues between
normal and abnormal embryo development and observed
a signiﬁcantly increased loss of imprinting in the abnormal
group, suggesting that the imprinting status of IGF-II may
be functionally related to embryo development.
In the sixth paper entitled “Eﬀects of assisted reproduction
technologyon placental imprinted geneexpression,” Katagiri et
al. investigate the impact of assisted reproductiontechniques
(ART) on imprinted gene expression in human placenta.
Diﬀerent changes in the mRNA levels of imprinted genes are
observed in the ART group compared with the spontaneous
conception group, suggesting that ART may modify epige-
netic status.
In the seventh paper entitled “Speciﬁcity of methylation
assays in cancer research: a guideline for designing primers and
probes,” Barekati et al. discuss the critical parameters to be
considered for a rational design of PCR primers used for
the detection of methylated DNA. The authors also provided
applicable tools/algorithms and useful websites.
Inthe eighthpaperentitled“Epigeneticregulatorymecha-
nisms associated with infertility,” Minocherhomji et al.review
the epigenetic mechanisms involved in spermatogenesis and
infertility. Topics discussed in detail include the regulation
and potential role of epigenetics in infertility by high-
order chromatin organization, epigenetic control of genes
associated with pericentromeric regions of chromosome 9
and Y, and noncoding RNAs.
In the ninth paper entitled “Hypermethylation of SOX2
promoter in endometrial carcinogenesis”, Wong et al. report
their studies on the methylation proﬁles of SOX2, a gene
encoding the stem cell-related transcription factor SOX2
in endometrial carcinomas. Compared to normal control
tissues, cancer tissues show hypermethylation and decreased
expression of SOX2. The authors conclude that epigenetic
silencing mechanisms may play a crucial role in transcrip-
tional regulation of SOX2 and loss of SOX2 expression.
Shi-Wen Jiang
Brian Brost
Sean Dowdy
Xing Xie
Fan Jin